Select Website
US Website
Hi, Sign in
My Market
Submit a Request for Quote
My Quote
Toggle Nav
Menu
Categories

Protein & Peptide Standards

View as List Grid
Set Descending Direction
per page

89 Items

  1. CCN10064P20

    13C 15N Ubiquitin in Solution

    CCN10064P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N
  2. CC10073P10

    13C fMLF

    CC10073P10
    3 - 6 weeks
    • 10 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C
    • Crystallized
  3. CC10073P20

    13C fMLF

    CC10073P20
    3 - 6 weeks
    • 20 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C
    • Crystallized
  4. CC10073P50

    13C fMLF

    CC10073P50
    3 - 6 weeks
    • 50 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C
    • Crystallized
  5. CCN10014P10

    13C, 15N Calbindin in Solution

    CCN10014P10
    3 - 6 weeks
    • 10 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
  6. CCN10014P20

    13C, 15N Calbindin in Solution

    CCN10014P20
    3 - 6 weeks
    • 20 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
  7. CCN10014P5

    13C, 15N Calbindin in Solution

    CCN10014P5
    3 - 6 weeks
    • 5 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N
  8. CCN10073P10

    13C, 15N fMLF

    CCN10073P10
    3 - 6 weeks
    • 10 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N
    • Crystallized
  9. CCN10073P20

    13C, 15N fMLF

    CCN10073P20
    3 - 6 weeks
    • 20 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N
    • Crystallized
  10. CCN10073P5

    13C, 15N fMLF

    CCN10073P5
    3 - 6 weeks
    • 5 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N
    • Crystallized
  11. CCN10073P50

    13C, 15N fMLF

    CCN10073P50
    3 - 6 weeks
    • 50 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N
    • Crystallized
  12. CCN10034P10

    13C, 15N GB1 in Solution

    CCN10034P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N
  13. CCN10034P20

    13C, 15N GB1 in Solution

    CCN10034P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N
  14. CCN10034P5

    13C, 15N GB1 in Solution

    CCN10034P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N
  15. CCN10044P10

    13C, 15N MBP in Solution

    CCN10044P10
    3 - 6 weeks
    • 10 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N
  16. CCN10044P20

    13C, 15N MBP in Solution

    CCN10044P20
    3 - 6 weeks
    • 20 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N
  17. CCN10044P5

    13C, 15N MBP in Solution

    CCN10044P5
    3 - 6 weeks
    • 5 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N
  18. CCN10033P10

    13C, 15N Microcrystalline GB1

    CCN10033P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N
  19. CCN10033P20

    13C, 15N Microcrystalline GB1

    CCN10033P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N
  20. CCN10033P5

    13C, 15N Microcrystalline GB1

    CCN10033P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N
  21. 13C, 15N Microcrystalline SH3

    13C, 15N Microcrystalline SH3

    CCN10053P20
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N
  22. 13C, 15N Microcrystalline SH3

    13C, 15N Microcrystalline SH3

    CCN10053P5
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N
  23. CCN10063P10

    13C, 15N Microcrystalline Ubiquitin

    CCN10063P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N
  24. CCN10063P20

    13C, 15N Microcrystalline Ubiquitin

    CCN10063P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N
  25. CCN10063P5

    13C, 15N Microcrystalline Ubiquitin

    CCN10063P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N
  26. CCN10054P10

    13C, 15N SH3 in Solution

    CCN10054P10
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N
  27. CCN10054P20

    13C, 15N SH3 in Solution

    CCN10054P20
    3 - 6 weeks
    • 20 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N
  28. CCN10054P5

    13C, 15N SH3 in Solution

    CCN10054P5
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6k Da
    • Labeling: 13C, 15N
  29. CCN10064P10

    13C, 15N Ubiquitin in Solution

    CCN10064P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N
  30. CCN10064P5

    13C, 15N Ubiquitin in Solution

    CCN10064P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N
  31. CCND10014P10

    13C, 15N, D Calbindin in Solution

    CCND10014P10
    3 - 6 weeks
    • 10 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
  32. CCND10014P20

    13C, 15N, D Calbindin in Solution

    CCND10014P20
    3 - 6 weeks
    • 20 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
  33. CCND10014P5

    13C, 15N, D Calbindin in Solution

    CCND10014P5
    3 - 6 weeks
    • 5 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
  34. CCND10073P10

    13C, 15N, D fMLF

    CCND10073P10
    3 - 6 weeks
    • 10 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  35. CCND10073P20

    13C, 15N, D fMLF

    CCND10073P20
    3 - 6 weeks
    • 20 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  36. CCND10073P5

    13C, 15N, D fMLF

    CCND10073P5
    3 - 6 weeks
    • 5 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  37. CCND10073P50

    13C, 15N, D fMLF

    CCND10073P50
    3 - 6 weeks
    • 50 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  38. CCND10034P10

    13C, 15N, D GB1 in Solution

    CCND10034P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N, D
  39. CCND10034P20

    13C, 15N, D GB1 in Solution

    CCND10034P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N, D
  40. CCND10034P5

    13C, 15N, D GB1 in Solution

    CCND10034P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N, D
  41. CCND10044P10

    13C, 15N, D MBP in Solution

    CCND10044P10
    3 - 6 weeks
    • 10 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N, D
  42. CCND10044P20

    13C, 15N, D MBP in Solution

    CCND10044P20
    3 - 6 weeks
    • 20 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N, D
  43. CCND10044P5

    13C, 15N, D MBP in Solution

    CCND10044P5
    3 - 6 weeks
    • 5 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N, D
  44. CCND10033P10

    13C, 15N, D Microcrystalline GB1

    CCND10033P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N, D
  45. CCND10033P20

    13C, 15N, D Microcrystalline GB1

    CCND10033P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N, D
  46. CCND10033P5

    13C, 15N, D Microcrystalline GB1

    CCND10033P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N, D
  47. 13C, 15N, D Microcrystalline SH3

    13C, 15N, D Microcrystalline SH3

    CCND10053P10
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  48. 13C, 15N, D Microcrystalline SH3

    13C, 15N, D Microcrystalline SH3

    CCND10053P20
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  49. 13C, 15N, D Microcrystalline SH3

    13C, 15N, D Microcrystalline SH3

    CCND10053P5
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  50. CCND10063P10

    13C, 15N, D Microcrystalline Ubiquitin

    CCND10063P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  51. CCND10063P20

    13C, 15N, D Microcrystalline Ubiquitin

    CCND10063P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  52. CCND10063P5

    13C, 15N, D Microcrystalline Ubiquitin

    CCND10063P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  53. 13C, 15N, D SH3 in Solution

    13C, 15N, D SH3 in Solution

    CCND10054P10
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  54. 13C, 15N, D SH3 in Solution

    13C, 15N, D SH3 in Solution

    CCND10054P20
    3 - 6 weeks
    • 20 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  55. 13C, 15N, D SH3 in Solution

    13C, 15N, D SH3 in Solution

    CCND10054P5
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 k Da
    • Labeling: 13C, 15N, D
  56. CCND10064P10

    13C, 15N, D Ubiquitin in Solution

    CCND10064P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  57. CCND10064P20

    13C, 15N, D Ubiquitin in Solution

    CCND10064P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  58. CCND10064P5

    13C, 15N, D Ubiquitin in Solution

    CCND10064P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  59. 13C15N Microcrystalline SH3

    13C15N Microcrystalline SH3

    CCN10053P10
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N
  60. CN10014P10

    15N Calbindin in Solution

    CN10014P10
    3 - 6 weeks
    • 10 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
  61. CN10014P20

    15N Calbindin in Solution

    CN10014P20
    3 - 6 weeks
    • 20 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
  62. CN10014P5

    15N Calbindin in Solution

    CN10014P5
    3 - 6 weeks
    • 5 mg
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded
    • Protein size: 8.5 kDa
    • Labeling: 15N
  63. CN10073P10

    15N fMLF

    CN10073P10
    3 - 6 weeks
    • 10 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 15N
    • Crystallized
  64. CN10073P20

    15N fMLF

    CN10073P20
    3 - 6 weeks
    • 20 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 15N
    • Crystallized
  65. CN10073P50

    15N fMLF

    CN10073P50
    3 - 6 weeks
    • 50 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 15N
    • Crystallized
  66. CN10034P10

    15N GB1 in Solution

    CN10034P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 15N
  67. CN10034P20

    15N GB1 in Solution

    CN10034P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 15N
  68. CN10034P5

    15N GB1 in Solution

    CN10034P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 15N
  69. CN10044P10

    15N MBP in Solution

    CN10044P10
    3 - 6 weeks
    • 10 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 15N
  70. CN10044P20

    15N MBP in Solution

    CN10044P20
    3 - 6 weeks
    • 20 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 15N
  71. CN10044P5

    15N MBP in Solution

    CN10044P5
    3 - 6 weeks
    • 5 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 15N
  72. CN10033P10

    15N Microcrystalline GB1

    CN10033P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 15N
  73. CN10033P20

    15N Microcrystalline GB1

    CN10033P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 15N
  74. CN10033P5

    15N Microcrystalline GB1

    CN10033P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 15N
  75. 15N Microcrystalline SH3

    15N Microcrystalline SH3

    CN10053P10
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 15N
  76. 15N Microcrystalline SH3

    15N Microcrystalline SH3

    CN10053P20
    3 - 6 weeks
    • 20 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 15N
  77. 15N Microcrystalline SH3

    15N Microcrystalline SH3

    CN10053P5
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 15N
  78. CN10063P10

    15N Microcrystalline Ubiquitin

    CN10063P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 15N
  79. CN10063P20

    15N Microcrystalline Ubiquitin

    CN10063P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 15N
  80. CN10063P5

    15N Microcrystalline Ubiquitin

    CN10063P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 15N
  81. CN10054P10

    15N SH3 in Solution

    CN10054P10
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 15N
  82. CN10054P20

    15N SH3 in Solution

    CN10054P20
    3 - 6 weeks
    • 20 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 15N
  83. CN10054P5

    15N SH3 in Solution

    CN10054P5
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 15N
  84. CN10064P10

    15N Ubiquitin in Solution

    CN10064P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 15N
  85. CN10064P20

    15N Ubiquitin in Solution

    CN10064P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 15N
  86. CN10064P5

    15N Ubiquitin in Solution

    CN10064P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 15N
  87. C10073P100

    unlabeled fMLF

    C10073P100
    3 - 6 weeks
    • 100 mg
    • Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Crystallized
  88. C10073P50

    unlabeled fMLF

    C10073P50
    3 - 6 weeks
    • 50 mg
    • Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Crystallized
  89. C10073P500

    unlabeled fMLF

    C10073P500
    3 - 6 weeks
    • 500 mg
    • Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Crystallized
View as List Grid
Set Descending Direction
per page

89 Items